A detailed history of Qube Research & Technologies LTD transactions in Iradimed Corp stock. As of the latest transaction made, Qube Research & Technologies LTD holds 34,159 shares of IRMD stock, worth $1.87 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
34,159
Previous 22,997 48.54%
Holding current value
$1.87 Million
Previous $1.01 Million 70.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$43.23 - $50.29 $482,533 - $561,336
11,162 Added 48.54%
34,159 $1.72 Million
Q2 2024

Aug 14, 2024

BUY
$40.36 - $44.7 $245,630 - $272,044
6,086 Added 35.99%
22,997 $1.01 Million
Q1 2024

May 14, 2024

BUY
$41.17 - $47.29 $470,408 - $540,335
11,426 Added 208.31%
16,911 $743,000
Q4 2023

Feb 13, 2024

BUY
$37.31 - $47.47 $101,483 - $129,118
2,720 Added 98.37%
5,485 $260,000
Q3 2023

Nov 13, 2023

BUY
$43.28 - $50.3 $119,669 - $139,079
2,765 New
2,765 $122,000

Others Institutions Holding IRMD

About IRADIMED CORP


  • Ticker IRMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 12,565,100
  • Market Cap $687M
  • Description
  • IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible pati...
More about IRMD
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.